Arctic Bioscience AS Statistics
Total Valuation
Arctic Bioscience AS has a market cap or net worth of NOK 342.49 million. The enterprise value is 264.94 million.
Market Cap | 342.49M |
Enterprise Value | 264.94M |
Important Dates
The last earnings date was Thursday, August 29, 2024.
Earnings Date | Aug 29, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Arctic Bioscience AS has 25.37 million shares outstanding. The number of shares has increased by 3.88% in one year.
Shares Outstanding | 25.37M |
Shares Change (YoY) | +3.88% |
Shares Change (QoQ) | -0.66% |
Owned by Insiders (%) | 18.34% |
Owned by Institutions (%) | 12.16% |
Float | 10.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.17 |
PB Ratio | 1.32 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.82 |
EV / Sales | 7.85 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -3.09 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.79.
Current Ratio | 3.36 |
Quick Ratio | 2.53 |
Debt / Equity | 0.79 |
Debt / EBITDA | n/a |
Debt / FCF | -0.02 |
Interest Coverage | -48.95 |
Financial Efficiency
Return on equity (ROE) is -16.68% and return on invested capital (ROIC) is -11.08%.
Return on Equity (ROE) | -16.68% |
Return on Assets (ROA) | -9.67% |
Return on Capital (ROIC) | -11.08% |
Revenue Per Employee | 1.99M |
Profits Per Employee | -2.68M |
Employee Count | 355 |
Asset Turnover | 0.11 |
Inventory Turnover | 0.70 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.11% in the last 52 weeks. The beta is 0.58, so Arctic Bioscience AS's price volatility has been lower than the market average.
Beta (5Y) | 0.58 |
52-Week Price Change | +42.11% |
50-Day Moving Average | 11.30 |
200-Day Moving Average | 10.09 |
Relative Strength Index (RSI) | 58.48 |
Average Volume (20 Days) | 11,365 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arctic Bioscience AS had revenue of NOK 33.76 million and -45.51 million in losses. Loss per share was -1.79.
Revenue | 33.76M |
Gross Profit | 9.78M |
Operating Income | -48.59M |
Pretax Income | -45.51M |
Net Income | -45.51M |
EBITDA | -45.79M |
EBIT | -48.59M |
Loss Per Share | -1.79 |
Balance Sheet
The company has 79.60 million in cash and 2.05 million in debt, giving a net cash position of 77.55 million or 3.06 per share.
Cash & Cash Equivalents | 79.60M |
Total Debt | 2.05M |
Net Cash | 77.55M |
Net Cash Per Share | 3.06 |
Equity (Book Value) | 258.56M |
Book Value Per Share | 10.19 |
Working Capital | 93.51M |
Cash Flow
In the last 12 months, operating cash flow was -40.29 million and capital expenditures -45.33 million, giving a free cash flow of -85.62 million.
Operating Cash Flow | -40.29M |
Capital Expenditures | -45.33M |
Free Cash Flow | -85.62M |
FCF Per Share | -3.37 |
Margins
Gross margin is 28.97%, with operating and profit margins of -143.93% and -134.84%.
Gross Margin | 28.97% |
Operating Margin | -143.93% |
Pretax Margin | -134.84% |
Profit Margin | -134.84% |
EBITDA Margin | -135.66% |
EBIT Margin | -143.93% |
FCF Margin | -253.65% |
Dividends & Yields
Arctic Bioscience AS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.88% |
Shareholder Yield | -3.88% |
Earnings Yield | -13.26% |
FCF Yield | -25.00% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |